RedCarpetLife
415
In the world today
Tse Ping & family

Tse Ping & family

T. family
-0.02% | - $-1.62M
$8.42 B ₹ 76,592 Cr
Real Time Net Worth #415 Ranking as of 21 Feb 2026 By Forbes

More on Tse Ping & family

Gender

Female

Age

74Y

Country

China

Born On

January, 1952

Deceased

No

Relationship Status

Married

Children

4

Education

Unknown

Designation Info :

Self-Made

No

Entrepreneur Type

Family Wealth

Primary Organization

Sino Biopharmaceutical

Titles

Executive Director

Sources of Wealth

Sino Biopharmaceutical

Industry

Pharmaceuticals, Healthcare

About Tse Ping & family


T se Ping, also known by her Chinese name Zheng Xiangling, is a Chinese pharmaceutical billionaire. Her fortune is derived from her family's massive stake in Sino Biopharmaceutical, one of China's largest and most successful drugmakers. She is the wife of Dhanin Chearavanont, the senior chairman of Thailand's Charoen Pokphand (CP) Group, one of Asia's most powerful conglomerates. Dhanin was the founder of Sino Biopharmaceutical, and the company has been run by their children.

Tse Ping serves as an executive director and vice chairwoman of the company. Her four children—two sons and two daughters—are all senior executives at the firm. The company has a strong focus on developing and marketing treatments for liver diseases, particularly hepatitis, which is a major health concern in China. The family's combined stake in the Hong Kong-listed pharmaceutical giant is the source of their immense, multi-billion dollar fortune, making them one of the wealthiest families in the global healthcare industry.

Advertisement

Quick Reads


  • Vice Chairwoman of the drugmaker Sino Biopharmaceutical.
  • Her husband is the Thai tycoon Dhanin Chearavanont, who founded the company.
  • Her four children are all top executives at the firm.
  • Sino Biopharmaceutical is one of China's largest drug companies.
  • The family's combined stake in the company is worth billions.

Early Life and Background


Tse Ping is a Hong Kong businessman, the self-made billionaire Founder and former Chairman of Sino Biopharmaceutical Ltd. (HKSE: 1177), a major global manufacturer of generic and proprietary pharmaceutical products. His career is rooted in pharmaceuticals, R&D, and entrepreneurial audacity.

Tse's philosophical approach centers on scale, technological excellence, and long-term commitment to affordable healthcare (pioneering the modern private pharmaceutical model). He founded Sino Biopharmaceutical in 1997, recognizing the immense, untapped domestic and international demand for high-quality, cost-effective drugs.

  • Sino Biopharmaceutical Ltd. (Founder & Former Chairman): The core publicly traded asset, a major global manufacturer of generic and proprietary drugs (specializing in oncology and hepatology).
  • Pharmaceutical Pioneer: His success is built on scale manufacturing and R&D in essential therapeutic areas (a key structural role in the global pharmaceutical supply chain).
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and R&D and leveraging the massive Chinese healthcare growth story (the shift to innovation).
  • Family Governance: His children, Theresa Tse and Eric Tse, are key executives in the company.

Career Journey of Tse Ping & family


Tse Ping's strategic genius was his commitment to R&D and scale. He founded Sino Biopharmaceutical in 1997, successfully building it into a global force by focusing on proprietary and generic drug manufacturing. His structural contribution is immense: pioneering the modern, scale pharmaceutical innovation model in China, providing essential medicines. The company successfully executed its IPO on the HKSE.

He retired as Chairman in 2020, transitioning the role to his daughter, Theresa Tse. His wealth is secured by the colossal, long-term, stable profitability of the global pharmaceutical and healthcare sector.

Advertisement

Tse Ping & family's Timeline


1997:

Founds Sino Biopharmaceutical Ltd. (Founding).

2000 (approx.):

Sino Biopharmaceutical executes its successful IPO on the HKSE (Financial Milestone).

2020 (June):

Steps down as Chairman, transitioning the role to his daughter, Theresa Tse (Executive Transition).

Ongoing:

Continues as Founder and major shareholder, guiding the global pharmaceutical giant (Executive Oversight).

Major Business Ventures and Investments


Tse Ping's wealth is concentrated in his founding equity and continued executive leadership of the publicly traded pharmaceutical giant, Sino Biopharmaceutical Ltd. (HKSE: 1177), and his private investments.

  • Sino Biopharmaceutical Ltd. (Founder & Former Chairman): The core publicly traded asset, a major global manufacturer of generic and proprietary drugs.
  • Pharmaceutical Pioneer: His success is built on scale manufacturing and R&D in essential therapeutic areas.
  • Family Governance: His children, Theresa Tse and Eric Tse, are key executives in the company.
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and R&D and leveraging the massive Chinese healthcare growth story.

Advertisement

Philanthropy and Social Impact


Tse Ping's social impact stems from Sino Biopharmaceutical's role in providing essential and affordable medicines, particularly for chronic diseases, improving healthcare access for millions of patients in China and internationally. The company actively supports educational and medical research initiatives through its foundations.

His personal philanthropy supports various community and educational initiatives.

Fashion, Style, and Lifestyle


Tse Ping maintains the professional, composed style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic reflects serious authority and stability, typical of a leader in the specialized pharmaceutical sector.

Residing in Hong Kong, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, technological innovation, and corporate governance.

Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is the Founder and Former Chairman of Sino Biopharmaceutical (pharmaceuticals).
  • His daughter, Theresa Tse, succeeded him as Chairwoman.
  • Sino Biopharmaceutical specializes in oncology and hepatology drugs.
  • His fortune is tied to the successful monetization and scale of the Chinese pharmaceutical innovation sector.
  • He successfully led the company's IPO on the HKSE.
  • His philosophy emphasizes long-term R&D and scale manufacturing.

Advertisement

More Profiles


Yin Yee Lee

-0.02% | -$0.35M

Bijan Tehrani

+50.26% | +$735.14M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content